Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study
Top Cited Papers
Open Access
- 7 April 2021
- journal article
- research article
- Published by Elsevier BV in The Lancet Microbe
- Vol. 2 (7), e311-e319
- https://doi.org/10.1016/s2666-5247(21)00056-2
Abstract
No abstract availableFunding Information
- Bill & Melinda Gates Foundation
- Federal Ministry for Economy and Technology
- European Commission
- German Federal Ministry of Health
This publication has 29 references indexed in Scilit:
- Rapid Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2017
- Probabilistic programming in Python using PyMC3PeerJ Computer Science, 2016
- Human Coronaviruses Associated with Upper Respiratory Tract Infections in Three Rural Areas of GhanaPLOS ONE, 2014
- Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell LinesmBio, 2012
- Comparison of the performance of the rapid antigen detection actim Influenza A&B test and RT-PCR in different respiratory specimensJournal of Medical Microbiology, 2009
- Plaque assay for human coronavirus NL63 using human colon carcinoma cellsVirology Journal, 2008
- Human Coronavirus NL63 and 229E Seroconversion in ChildrenJournal of Clinical Microbiology, 2008
- Human Coronavirus Infections in Rural Thailand: A Comprehensive Study Using Real‐Time Reverse‐Transcription Polymerase Chain Reaction AssaysThe Journal of Infectious Diseases, 2007
- Frequent Detection of Human Coronaviruses in Clinical Specimens from Patients with Respiratory Tract Infection by Use of a Novel Real‐Time Reverse‐Transcriptase Polymerase Chain ReactionThe Journal of Infectious Diseases, 2004
- Two-sided confidence intervals for the single proportion: comparison of seven methodsStatistics in Medicine, 1998